Glaxosmithkline



Ebit تغيير تاريخ
AbbVie USD 5.24B 1.5B 2024-12
Amgen USD 4.03B 11M 2024-12
AstraZeneca USD 4.2B 119M 2024-12
Aurora Cannabis CAD 36.86M 39.25M 2024-12
Bausch Health Companies USD 861M 463M 2024-09
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Canopy Growth CAD -23822000 22.12M 2024-12
Corcept Therapeutics USD 25.26M 20.34M 2024-12
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Indivior 9M 51M 2024-09
J&J USD 5.35B 1.14B 2024-12
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Pacira USD 56.14M 7.23M 2024-12
Perrigo USD 193.9M 11.5M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Prestige Brands USD 91.96M 7.62M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.08B 1.69B 2024-12
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12
Takeda JPY 58B 129.82B 2024-12
Teva Pharmaceutical Industries USD 1.17B 100M 2024-12
Zoetis USD 988M 30M 2024-12



Glaxosmithkline - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.